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doi:10.1016/j.ejvs.2008.11.017Abstract Objectives: This study used the whole transcriptome approach to investigate the
role of genes involved in immune and inflammatory response at the site of aneurysm rupture.
Materials and methods: Rupture site and paired anterior sac biopsies (internal control) of
ruptured abdominal aortic aneurysms (AAAs) (nZ 10) were analysed with Affymetrix Human
Genome U133A plus 2.0 microarray. Twenty-one differentially expressed genes were selected
for validation using quantitative reverse transcriptase polymerase chain reaction (QRT-PCR).
Results: A total of 139 genes (123 upregulated, 16 downregulated) at the aneurysm rupture
site were differentially expressed (>2.5-fold, P< 0.005). Immune and inflammatory responses
(Gene Ontology Classification) were frequently associated with the differentially expressed
genes. Genes with immune and inflammatory functions that were confirmed, by QRT-PCR, to
be overexpressed at the aneurysm rupture site were interleukins-6 and -8 (IL-6 and -8), Selec-
tin E (SELE), prostaglandin-endoperoxidase synthase 2 (COX2) and prokineticin 2 (PROK2). IL-6
(pro-immune) and IL-8 (pro-immune and pro-inflammatory) have previously been linked to
aneurysm rupture; and SELE and COX2 (pro-inflammatory) have previous associations with
aneurysm development but not rupture.
Conclusions: The differential expression of genes involved in immune and inflammatory
responses was confirmed at AAA rupture site. These genes may represent novel targets for
treatment of aneurysms.
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306 E. Choke et al.The rupture of abdominal aortic aneurysms (AAAs) is
responsible for 1.5% of the total mortality in males over 55
years of age.1 Currently, there is no pharmacological
treatment available to retard aneurysm expansion or
rupture, and surgical repair by conventional or endovas-
cular means remains the only treatment option. Although
considerable research has been applied to the aetiology
and mechanism of aneurysm development, the processes
underlying aneurysm rupture remain poorly defined.
Mechanisms of aneurysm rupture have not been revealed
from studies that compared the composition of aneurysm
sac from ruptured and non-ruptured aneurysms, suggest-
ing that global changes in biological activity within the
aneurysm sac were not responsible for aneurysm
rupture.2,3
Studies which investigated whether localised factors at
the site of aortic rupture were accountable for aneurysm
rupture, rather than global changes, proved to be more
fruitful. These investigations demonstrated that tissues
from the site of aneurysm rupture exhibited localised
upregulation of proteolysis and angiogenesis.2,3 The find-
ings from these studies suggested that, within a given
aneurysm, there may be discrete microenvironments or
‘hot spots’4 of altered biological activities giving rise to
weakened areas of aneurysm wall that are predisposed to
rupture.
Using microarray analysis, we have previously reported
that the site of aneurysm rupture had a unique gene-
expression profile5 when compared to paired anterior sacs;
therefore, supporting the concept of ‘hot spots’ of altered
biological activities. The present study analysed the bio-
logical processes represented by the differentially
expressed genes and focused on the role of genes involved
in immune and inflammatory responses. The immune and
inflammatory systems have been implicated in AAA forma-
tion and progression6,7 by their capacity to induce the
expression and activation of proteolytic enzymes.8 The
current study validated several of the pro-immune and pro-
inflammatory genes previously studied; however, it also
extended the roles of some of these genes to include
aneurysm rupture. These data could, in turn, provide
a reference framework for the development of protective
medical strategies specifically targeted at preventing
aneurysm rupture.
Materials and Methods
Sample collection
This study was approved by the Local Research Ethics
Committee (Wandsworth, London). Ten consecutive
patients who underwent emergency transperitoneal repair
for ruptured AAA (rAAA) were recruited. The mean age was
75 (range: 61e82). During aneurysm repair, the rupture site
was identified and a strip of aortic wall including the
aneurysm rupture site was carefully excised. All of the
rupture sites were located posteriorly. Aneurysm rupture-
site tissue was defined as 5-mm cuff of tissue immediately
adjacent to the edge of rupture. Paired tissues acting as
control were obtained from the anterior aneurysm sacs at
the same level as the rupture-site samples and at least 3 cmaway from the rupture site. Rupture-site samples were then
compared to anterior sac samples using the methodology
described below.
Tissue processing
To facilitate molecular analysis, samples were washed with
RNALater (Ambion, UK) to remove blood. Adherent mural
thrombus and excess adventitia were carefully dissected
from the aortic wall and excluded from analysis.
Immunohistochemistry
Immunohistochemistry was performed with a labelled
streptavidinebiotin method, using antibodies to a-actin
smooth muscle (a-SMA) (Clone 1A4 diluted 1:100, DAKO,
UK) to confirm that specimens consisted of aortic wall with
minimal adherent thrombus.
Total RNA extraction
Samples were ground to a fine powder in liquid nitrogen,
and total RNA was extracted (RNeasy Fibrous Tissue RNA
extraction kit, Qiagen, UK). The integrity and concentra-
tion of the extracted total RNA were tested using RNA 6000
Nano LabChip Kit and Agilent 2100 Bioanalyzer (Agilent
Technologies). Features of successful total RNA run on the
electrophoresis and electropherograms were one marker
peak and two ribosomal (18s and 28s) peaks (Supplement
Fig. 1).
As aneurysm rupture-site tissue was limited to a 5-mm
cuff of tissue immediately adjacent to the edge of rupture,
the amount of total RNA extracted per rupture-site sample
was limited to approximately 6e7 mg. With the currently
available kits, it is now possible to perform microarray
analysis on small amounts of total RNA (1e5 mg). However,
when this study was carried out, a minimum of 10e15 mg of
total RNA was required for each microarray GeneChip
analysis (allowing for quality control and repeat reactions
as necessary). It was, therefore, not possible to perform
microarray analysis individually for each patient in the
present study.
Pooled total RNA from the rupture site (nZ 10) was,
therefore, analysed against pooled total RNA from anterior
sac (nZ 10). We acknowledge that this approach can
increase both false-positive and -negative results, because
the observed variation between two arrays may be due to
the arrays themselves.9 Consequently, three replicates
were performed for each pool in this study to reduce
misclassification rates in gene expression as validated in
previous studies.10 Yields per mg of tissue were not signif-
icantly different between the 10-paired samples. Equiva-
lent amounts of RNA (5 mg) were taken from every rupture
site or anterior sac samples to make up 50 mg total RNA in
each pool.
Microarray analysis
Affymetrix chip processing was performed at the John Innes
Centre Genome Laboratory (Norwich, UK) according to the
Affymetrix Manual II.
Figure 1 Histological example of serial sections of full-
thickness aortic wall showing the various layers of abdominal
aortic aneurysm wall (TM) tunica media and (TA) tunica
adventitia. A, Control (counterstained with haematoxylin). B,
Low power (50) image demonstrating tunica media consisting
of a-SMA-positive smooth muscle cells.
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Expression-profile data were first prepared using Microarray
suite 5.0 (Affymetrix) and subsequently exported to Gene-
Spring 5.0 Microarray Analysis Software (Silicon Genetics,
Redwood City, CA) for normalisation and statistical anal-
ysis. The robust multi-array average (RMA) algorithm was
used to normalise the Affymetrix probe-set data into gene-
expression levels for all samples.
Quantitative real-time reverse transcriptase
polymerase chain reaction (RT-PCR)
Selected differentially expressed genes were each vali-
dated by quantitative reverse transcriptase polymerase
chain reaction (QRT-PCR) (Mx4000 Multiplex Quantitative
PCR System, Stratagene, UK) using TaqMan Gene Expres-
sion Assays and TaqMan Universal PCR Master Mix (Applied
Biosystems, UK). For validation studies by QRT-PCR, indi-
vidual pairs were used for analysis (nZ 10) rather than
pooled samples. All samples were run in triplicate, and 18s
rRNA was used as an internal control to normalise transcript
levels.
Statistics
All data are reported as mean SEM. For microarray anal-
ysis, genes showing differential expression were identified
by filtering, using the following criteria: (1) P value less
than 0.005 and (2) 2.5-fold difference in the mean signal
between rupture site and anterior sac. Entrez Gene,
available at the NCBI home page (www.ncbi.nlm.nih.gov),
was used to identify all known gene ontology (GO)
processes associated with the products of these filtered,
differentially expressed genes. Benjamin-Hoechberg
multiple testing correction was used.
QRT-PCR-validated mRNA expression of selected genes
between rupture site and anterior sac was assessed using
paired two-tailed Student’s t-test. For QRT-PCR, P< 0.05
was considered significant.
Results
Immunohistochemical analysis
The medial layer was identified by the abundance of a-SMA-
positive smooth muscle cells (Fig. 1). As all specimens were
confirmed to consist of full-thickness aortic wall tissues
with minimal adherent thrombus, all 10 pairs of rupture
sites and anterior sacs were subjected to molecular anal-
yses. Histologically, the quality of tissue between rupture
site and anterior sac specimens was very similar.
Microarray analysis
A total of 139 genes (123 upregulated and 16 down-
regulated) had a >2.5-fold difference of expression
(P< 0.005) at the aneurysm rupture site compared to
paired anterior sac (Supplement Tables 1 and 2). Three
genes were differentially expressed >20-fold, nine genes>10-fold and 24 genes >5-fold. The greatest fold-differ-
ential expressions were 34.4-fold upregulation of the
E-selectin gene and eightfold downregulation of d-like
1 homolog (Drosophila).
Gene ontology processes
When genes were analysed according to the GO processes,
the differentially expressed genes contributed to 287
different GO biological processes (Appendix Supplemental
Information). The number of differentially expressed genes
annotated under each of these GO processes varied from 1
to 28. Thirty-three (11.5%) GO processes were contributed
by four or more differentially expressed genes (Table 1).
Immune response, signal transduction, cellecell signaling
and inflammatory response were the processes most
frequently associated with the differentially expressed
genes. Immune and inflammatory responses have previously
been demonstrated to be associated with the pathogenesis
of aneurysms,11 but not aneurysm rupture. Four overex-
pressed genes were annotated under the GO process
angiogenesis, a biological process known to be increased at
the site of aneurysm rupture.2
Quantitative real-time RT-PCR analysis of gene
expression
Differential expression of selected pro-immune and pro-
inflammatory genes was validated by quantitative real-time
RT-PCR using 18s rRNA as a reference gene (Table 2). These
included E-selectin (SELE), prostaglandin-endoperoxide
synthase 2 (COX2) and interleukins-6 and -8 (IL-6 and -8)
genes which were selected on the basis of their previous
known associations with aortic aneurysm development.12e21
Prokineticin 2 gene was selected, based on its high level of
overexpression at the site of rupture (more than sevenfold)
and its known pro-angiogenic function in addition to its pro-
inflammatory function. All of these selected pro-immune
and pro-inflammatory genes were validated to be upregu-
lated at the site of aneurysm rupture by QRT-PCR.
Other genes were also selected for validation by QRT-
PCR to make up a total of 21 genes altogether. The
Table 1 Gene ontology processes associated with differ-
entially expressed genes
Gene ontology processes
(http://www.ncbi.nlm.nih.gov)
Counta %b
Immune response 28 20
Signal transduction 27 18.7
Cellecell signaling 19 12.9
Inflammatory response 18 13.6
Chemotaxis 17 12.2
Apoptosis 10 7.1
Cell proliferation 10 7.1
Protein folding 10 7.1
Biological process 9 6.4
Cell surface receptor linked signal
transduction
9 6.4
Multicellular organismal development 9 6.4
Cell adhesion 8 5.7
Transcription 8 5.7
Anti-apoptosis 7 5
Negative regulation of cell proliferation 7 5
Regulation of transcription, DNA-dependent 7 5
Response to unfolded protein 7 5
Positive regulation of cell proliferation 6 4.3
G-protein coupled receptor
protein signaling pathway
6 4.3
Regulation of progression through cell cycle 6 4.3
Cell differentiation 5 3.6
Cell motility 5 3.6
Defense response to bacterium 5 3.6
Induction of apoptosisa 5 3.6
Intracellular signaling cascade 5 3.6
Angiogenesis 4 2.9
Antimicrobial humoral response
(sensu vertebrata)
4 2.9
Blood coagulation 4 2.9
Caspase activation 4 2.9
Neutrophil chemotaxis 4 2.9
Organ morphogenesis 4 2.9
Positive regulation of transcription
from RNA polymerase II promoter
4 2.9
Protein modification 4 2.9
aNumber of differentially expressed genes annotated under term.
bPercent of differentially expressed genes annotated under
term.
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expression, previous interest within our group, contribution
to the GO processes and the potential contribution to
aneurysm rupture. As this article is focused on the role of
immune and inflammatory responses in aneurysm rupture,
the analysis of the genes involved in other biological
processes (e.g., angiogenesis, apoptosis and proteolysis)
are limited to Supplementary Table 4 only.
Discussion
We have previously published a preliminary report on genes
with altered expressions at the aneurysm rupture site using
microarray analysis.5 The present study was a morein-depth identification of differentially expressed pro-
immune and pro-inflammatory genes at the site of aneu-
rysm rupture. In this article, a more stringent cut-off point
of P< 0.005 was applied (instead of P< 0.015) and,
therefore, smaller numbers of differentially expressed
genes were identified (139 versus 624). In addition, the
present study subjected a total of 21 genes to validation by
QRT-PCR, compared to only three genes in the earlier short
article.5
Tissues 3 cm away from the rupture site were chosen as
control tissues, because previous investigations2 demon-
strated that an aneurysm rupture site had different bio-
logical properties (increased angiogenic response)
compared to tissues 3 cm away from the rupture site.
Furthermore, data from the same study2 revealed that
tissues 3 cm away from the rupture site exhibited no
significant difference in levels of angiogenic response,
compared to control tissues taken from other non-rupture
sites (anterior sac) from the same aneurysm. This suggested
that, in terms of extent of angiogenesis, tissues 3 cm away
from the rupture site were no longer ‘hot spots’.
This study used the whole transcriptome approach to
characterise the gene-expression profile of the aneurysm
rupture site. Application of a 2.5-fold cut-off in gene-
expression difference (P< 0.005), as representing a signifi-
cant value, identified 139 differentially expressed genes.
Expression of the majority of genes (123) was increased,
whilst expression of only 16 genes was decreased. Of the 21
genes selected for QRT-PCR analysis in individual patient,
paired tissues, 17 were confirmed as being differentially
expressed. The biological processes represented by these
differentially expressed genes included immune response,
inflammatory response, apoptosis, protein modification and
proteolysis, angiogenesis and blood coagulation (plasmin-
ogen activator system). Whilst angiogenesis,2 proteolysis3
and plasminogen activator system22 have been shown to be
linked with aneurysm rupture, this is the first study to
implicate inflammation and immune responses as potential
participants in aneurysm rupture.
Previous studies have provided evidence for the
involvement of the immune and inflammatory system in
AAA development.8 A prominent histological feature of
AAAs is extensive inflammatory infiltration consisting of T
cells, B cells, macrophages, neutrophils and natural killer
(NK) cells.23e25 The trigger for the recruitment of inflam-
matory and immune cells is not yet known, but may include
the increased local production of chemotactic cytokines
such as IL-8, MCP-1 and RANTES (regulated on activation
normal T-cell expressed and secreted).26 Human and
experimental AAA tissues have also been shown to produce
abundant amounts of prostaglandin E2 (PGE2), tumor
necrosis factor-a (TNF-a), interleukin-1b (IL-1b) and
interleukin-6 (IL-6).11,13,27,28
The contributions of various components of the immune
and inflammatory system have also been tested in animal
models of AAA. Inflammatory cells, including neutrophils, T
cells and macrophages, have been found to play important
roles in the formation of experimental aneurysms.29,30 In
addition, various other immune-related molecules
including NFkB, c-Jun N-terminal kinase, P47phox, inter-
feron gamma (IFNg) and IL431e33 have been found to be
involved in the formation of experimental aneurysms.
Table 2 Confirmation of differential gene expression of pro (P< 0.005 and more than 2.5-fold difference in expression) by
QRT-PCR
Gene name Gene
ontology
process
Abbreviation Fold
change
(Affymetrix)
Fold
change
(QRT-PCR)
Previous association
with aortic
aneurysm
Previous association
with aortic
aneurysm rupture
Selectin E (endothelial
adhesion molecule 1)
Inflammation SELE 34.42 4.32* 12
Prostaglandin-endoperoxide
synthase 2 (prostaglandin
G/H synthase
and cyclooxygenase)
Inflammation COX2 10.14 6.82*** 13,14
Prokineticin 2 Inflammation PROK2 7.009 10.4**
Interleukin-6
(interferon, beta 2)
Immune IL-6 6.881 12.6** 15,16 18
Interleukin-8 Inflammation
and immune
IL-8 6.108 22.7*** 17e21 18
*PZ<0.05; **P0Z<0.01; ***PZ<.001.
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a major role in tissue injury by inducing the expression and
activation of proteolytic enzymes. Although chronic
inflammation is a dominant feature of established AAAs;
the role of inflammation in aneurysm rupture has never
been demonstrated before. In fact studies have reported
that, within the aneurysm rupture site, the increases in
proteolytic enzymes33 and angiogenic activity2 were not
associated with any increase in numbers of inflammatory
cells. These findings are, therefore, somewhat contradic-
tory to those of the present study which has identified
overexpression of genes encoding for the following
immune-regulating or pro-inflammatory molecules (IL-8,
IL-6, PTGS2, PROK2 and SELE) at the aneurysm rupture site.
A possible explanation for this is that the inflammatory
cytokines that constitute a significant proportion of upre-
gulated genes at the rupture site may play a role in
increasing the bioreactivity of the inflammatory cells so
that, even though the extent of inflammatory infiltrate may
remain unaltered, the level of activity of these inflamma-
tory cells are enhanced.
There were several limitations to this study. All ruptures
occurred in the posterior wall and control tissues were
taken from anterior sacs. Therefore, some of the differ-
ences identified may be accounted for by inherent differ-
ences between posterior wall and anterior wall tissues.
Secondly, differences in global gene expression between
ruptured and non-ruptured elective aneurysm may exist,
and this would also be an interesting hypothesis to test in
future work. Another limitation to this study is the lack of
quantification at the protein level. However, rupture-site
tissues were limited to the 5-mm cuff of tissue immediately
adjacent to the edge of rupture. If tissues further away
than this were used, this study would risk using tissues that
were not truly representative of the rupture site. Unfor-
tunately, limitation of the amount of tissues meant that
there were not enough tissues available for either protein
quantification or immunohistological identification of the
cellular sources of the upregulated gene. A further limita-
tion was that the tissues were obtained at various time
points after the rupture event, and some of the changesreported could, therefore, be due to temporal changes in
gene expression, which can occur rapidly, within 1 h.
This study has identified pro-immune and pro-inflam-
matory genes with altered expression between aneurysm
rupture site and anterior sac. Functional analysis of these
candidate genes will be needed to determine if their
differential expression is important in aneurysm rupture.
This work will require evaluation in experimental models of
aortic rupture to separate cause from effect.
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